热景生物(688068.SH)网上中签号码共1.18万个 山证创新投资获配77.75万股
格隆汇9月19日丨热景生物(688068.SH)发布首次公开发行股票并在科创板上市网下初步配售结果及网上中签结果公告,战略配售结果如下:

网上摇号中签结果如下:

凡参与网上发行申购热景生物股票的投资者持有的申购配号尾数与上述号码相同的,则为中签号码。中签号码共有1.18万个,每个中签号码只能认购500股热景生物股票。
网下发行申购情况及初步配售结果如下:
此次发行的网下申购工作已于2019年9月18日(T日)结束。经核查确认,《发行公告》披露的302家网下投资者管理的3405个有效报价配售对象均按照《发行公告》的要求进行了网下申购,为有效申购投资者,网下有效申购数量680310万股。
网下初步配售结果:

网下配售摇号抽签如下:
发行人与保荐机构(主承销商)定于2019年9月23日(T+3日)上午在上海市浦东东方路778号紫金山大酒店四楼会议室海棠厅进行本次发行网下限售账户的摇号抽签,并将于2019年9月24日(T+4日)在《上海证券报》、《中国证券报》、《证券时报》和《证券日报》披露的《北京热景生物技术股份有限公司首次公开发行股票并在科创板上市发行结果公告》中公布网下限售账户摇号中签结果。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of this article is for reference only. It does not constitute an offer, solicitation, recommendation, opinion or guarantee of any securities, financial products or instruments.The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance.